Global Dried Blood Spot Collection Cards Market Size to Exceed USD 559.50 Million by 2033: Market Statistics Report

Global Dried Blood Spot Collection Cards Market Size to Exceed USD 559.50 Million by 2033                   

According to a research report published by Spherical Insights & Consulting, The Global Dried Blood Spot Collection Cards Market is Expected to Grow from USD 357.70 Million in 2023 to USD 559.50 Million by 2033, at a CAGR of 4.58% during the forecast period 2023-2033. 

Browse 210 Market Data Tables and 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Dried Blood Spot Collection Cards Market Size, Share, and COVID-19 Impact Analysis, By Card Type (Whatman 903 and Ahlstrom 226), By Application (Newborn Screening, Infectious Disease Testing, Forensics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Dried blood spot analysis is a minimally invasive bio-sampling method where blood samples are dried and blotted on filter paper. These samples are then shipped to an analytical laboratory under ambient conditions for the necessary analysis. A few of the uses of dried blood spot collection cards are systems biology, drug development, forensic science, and biomarker discovery and validation. Furthermore, the market is increasing due to the increased application of dried blood spots for the diagnosis of viral and autoimmune diseases. The market is increasing because the utilization of dried blood spots also offers effective, as well as early diagnosis, convenient alternatives to plasma-based testing, storage, and easy collection with limited laboratory infrastructure. However, conversely, increased reliance, contamination, and sufficient sampling. The market would be hampered by developing economies' lack of infrastructure for healthcare and shortage of qualified workers.

The Whatman 903 segment held the largest share in 2023 and is anticipated to grow at a CAGR of 39.57% during the forecast period.

Based on the card type, the global dried blood spot collection cards market is categorized into Whatman 903 and Ahlstrom 226. Among these, the Whatman 903 segment held the largest share in 2023 and is anticipated to grow at a CAGR of 39.57% during the forecast period. Whatman paper is a particular filter paper used heavily in qualitative analysis. Among the other types of paper, Whatman 903 filter paper is FDA-approved as an in vitro Class II medical device, and it is used in most newborn screening programs globally.

The newborn screening segment accounted for the largest share in 2023 and is estimated to grow at a CAGR of 22.13% during the forecast period. 

Based on the application, the global dried blood spot collection cards market is categorized into newborn screening, infectious disease testing, and forensics. Among these, the newborn screening segment accounted for the largest share in 2023 and is estimated to grow at a CAGR of 22.13% during the forecast period. Newborn screening is generally intended for the detection of pre-symptomatic disorders to organize an efficient early intervention. Clinical laboratories are conducting prospective pilot studies to optimize workflow and analytical performance of screening tests.

North America is estimated to hold the highest share of the global dried blood spot collection cards market over the predicted timeframe.

North America is estimated to hold the highest share of the global dried blood spot collection cards market over the predicted timeframe. This is since there are numerous manufacturers and established childcare centers in the area. Furthermore, DBS procedure guidelines by public bodies guarantee quality products, thereby leading to more dependency on researchers & clinicians, thus contributing to overall demand for the market in North America.

Europe is anticipated to hold the largest share of the global dried blood spot collection cards market over the predicted timeframe. This was determined to be a profitable area for this sector. Growing investments in the creation of cutting-edge diagnostics solutions and the increase in the incidence of infectious and chronic diseases are responsible for the market's expansion in the area.

Company Profiling

Major vendors in the global dried blood spot collection cards market are Roche, Ahlstrom-Munksjö, Centogene N.V., Pall Corporation, Eastern Business Forms, Inc., Shimadzu Corporation, QIAGEN, Archimed Life Science Gmbh, and Perkinelmer and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent development 

• In February 2025, Tasso, Inc., the exclusive developer of patient-friendly, clinical grade blood collection solutions, now introduces its new generation technology for dried blood spot (DBS) sample collection. The revolutionary collection system includes Tasso's new Tile™-T20 dried whole blood cartridge and Tasso™ Mini device, to allow for accurate, easy DBS sample collection for clinical studies and sports anti-doping purposes.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global dried blood spot collection cards market based on the below-mentioned segments: 

Global Dried Blood Spot Collection Cards Market, By Card Type

• Whatman 903
• Ahlstrom 226

Global Dried Blood Spot Collection Cards Market, By Application

• Newborn Screening
• Infectious Disease Testing
• Forensics

Global Dried Blood Spot Collection Cards Market, By Regional

• North America 
  • US
  • Canada
  • Mexico
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America 
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa 
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa